State of Wisconsin Investment Board lifted its holdings in shares of Elanco Animal Health (NASDAQ:ELAN) by 460.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 284,805 shares of the company’s stock after buying an additional 233,995 shares during the quarter. State of Wisconsin Investment Board’s holdings in Elanco Animal Health were worth $9,134,000 at the end of the most recent quarter.
Other hedge funds have also made changes to their positions in the company. Sterling Investment Advisors Ltd. bought a new stake in Elanco Animal Health during the 1st quarter worth approximately $25,000. Ropes Wealth Advisors LLC bought a new stake in Elanco Animal Health during the 1st quarter worth approximately $25,000. Water Island Capital LLC bought a new stake in Elanco Animal Health during the 1st quarter worth approximately $27,000. FTB Advisors Inc. bought a new stake in Elanco Animal Health during the 1st quarter worth approximately $29,000. Finally, Krensavage Asset Management LLC increased its holdings in Elanco Animal Health by 0.5% during the 4th quarter. Krensavage Asset Management LLC now owns 200,967 shares of the company’s stock worth $6,336,000 after acquiring an additional 967 shares during the period.
A number of research firms recently weighed in on ELAN. Zacks Investment Research lowered shares of Elanco Animal Health from a “buy” rating to a “hold” rating in a report on Tuesday, May 21st. Guggenheim began coverage on shares of Elanco Animal Health in a report on Wednesday, May 22nd. They set a “neutral” rating on the stock. BMO Capital Markets upped their target price on shares of Elanco Animal Health from $32.00 to $35.00 and gave the stock a “market perform” rating in a report on Friday, May 10th. UBS Group initiated coverage on shares of Elanco Animal Health in a report on Wednesday, March 20th. They set a “sell” rating and a $28.00 target price on the stock. Finally, Bank of America raised shares of Elanco Animal Health from a “neutral” rating to a “buy” rating and set a $30.95 price target on the stock in a report on Monday, March 18th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and six have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $33.47.
Shares of NASDAQ:ELAN opened at $31.95 on Friday. Elanco Animal Health has a one year low of $28.00 and a one year high of $37.61.
Elanco Animal Health (NASDAQ:ELAN) last issued its quarterly earnings results on Thursday, May 9th. The company reported $0.25 EPS for the quarter, topping the Zacks’ consensus estimate of $0.22 by $0.03. The company had revenue of $731.10 million during the quarter, compared to the consensus estimate of $743.40 million. Elanco Animal Health’s quarterly revenue was down .7% on a year-over-year basis. During the same period in the previous year, the company earned $0.33 EPS.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://sportsperspectives.com/2019/06/16/state-of-wisconsin-investment-board-acquires-233995-shares-of-elanco-animal-health-nasdaqelan.html.
Elanco Animal Health Company Profile
There is no company description available for Elanco Animal Health Inc
Featured Article: The role of implied volatility with call option volume
Want to see what other hedge funds are holding ELAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elanco Animal Health (NASDAQ:ELAN).
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.